Review Redefining Mitochondrial Therapy for ME/CFS: The Case for MOTS-c, 2025, Klimas et al

[Utsikt]

So what happened then? They wrote the text without checking the references, asked AI to find some to back up their arguments, it failed, and then they had to go digging themselves?

 

[ChronicallyOverIt]

I saw a push for MOTS-C and SS-31 on twitter a few months ago. I wonder if this fits with the timing. Or someone capitalizing on a new patient population to sell too?

I for one and scared to death of buying random peptides from labs in China. I can’t imagine injecting these without real GMP validation of manufacturing.